Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Mar 12, 2025 10:08pm
RE:RBC
Nice. How much more good news does this stock need to get going?
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 12, 2025 3:17pm
CIBC
The Globe and Mail asked money managers how they’re navigating the market mayhem under U.S President Donald Trump, and whether it’s time to “buy the dip” or to take cover. Craig Jerusalim, senior
...more
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 12, 2025 8:48am
RBC
March 11, 2025 DRI Healthcare Trust Arvinas announced mixed topline results from Ph3 trial - Implications for Orserdu TSX: DHT-U | CAD 11.80 | Outperform | Price
...more
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Mar 10, 2025 6:54pm
RE:Another View of Earnings
I don't think 5i looks at things too closely. It was CIBC that lowered its target. And more meaningful in my view was the plan to internalize mgmt, which was discussed at length on the call. I
...more
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 09, 2025 1:40pm
Another View of Earnings
Revenue of $62M beat estimates of $42.5M by a wide margin. Adjusted EPS of 76c beat estimates of 45c. CIBC raised its target price, National lowered it. Cash flow rose 45%. Net earnings did decrease
...more
(12)
•••
raybay_98
X
Comment by
raybay_98
on Mar 06, 2025 1:41pm
RE:RE:RE:Up and Down
Koodoos to you sir! IMHO, you have more insight than all the analysts put together!
(43)
•••
profitprophet1
X
Post by
profitprophet1
on Mar 06, 2025 12:46pm
Dri Healthcare analyst comments
Its fourth quarter results are in the books and Raymond James analyst Michael W. Freeman still thinks there is money to be made on DRI Healthcare Trust (DRI Healthcare Trust Stock Quote, Chart, News
...more
(32)
•••
junglejames
X
Comment by
junglejames
on Mar 06, 2025 8:54am
RE:RE:Up and Down
Most analysts estimates are "blue sky" in that they largely ignore any form of risk. It is a good exercise to do a historical plot of the pool of analysts extimates against the
...more
(23)
•••
HermannHaller
X
Comment by
HermannHaller
on Mar 05, 2025 2:30pm
RE:Up and Down
Did you see the CIBC note? I'm curious why he would lower his target after a strong quarter and positive comments about internalizing mgmt.
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 05, 2025 11:00am
One More
Canaccord Genuity’s Tania Armstrong-Whitworth to $20.50 from $19 with a “buy” rating.
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 05, 2025 9:05am
Up and Down
NB reversed their recent lowering of the SP following these results. GLTA CIBC’s Scott Fletcher cut his DRI Healthcare Trust target to $16 from $18 with an “outperformer” rating, while National Bank
...more
(6300)
•••
retiredcf
X
Post by
retiredcf
on Mar 05, 2025 8:54am
RBC 2
Their upside scenario target is $21.00. And yes, DHT.UN was a lone beacon of green yesterday in a sea of red. GLTA March 4, 2025 Outperform TSX: DHT-U
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 05, 2025 8:11am
New Press Release - Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday
TORONTO, March 5, 2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN/DHT.U) ("DRI" or "the Trust") today informs its unitholders of an adjustment to its previously announced quarterly cash distribution to unitholders of record as at March 31, 2025. This adjustment is required due to the occurrence of...
read article.
(70)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Mar 04, 2025 7:42pm
RE:CIBC
Thx retiredcf. Imagine the reaction to this great report if markets weren't big red! I hope that Mr Market doesn't forget the good news in the mango-made chaos. It sure seemed from
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining
Have you held units of a TD mutual fund through a discount broker? Learn more.